Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
US National OCS Liver Perfusion (OLP) Registry
for
Liver Transplant
Location: Dallas TX, Houston TX, San Antonio TX, Saint Louis MO,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05940857
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Dallas TX, Houston TX, San Antonio TX, Little Rock AR,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
for
Relapsed or Refractory Acute Myeloid Leukemia (AML),
Location: Dallas TX, Houston TX, Charleston SC
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT02074839
Phase1, Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Dallas TX, Chicago IL, Portland OR
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase2, Recruiting
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
for
Liver Fibroses, Cirrhosis
Location: Dallas TX, Boston MA
Sponsor: Raymond Chung
Sex: All
Age: 18+
Code: NCT05028829
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Dallas TX, Austin TX, Kansas City KS, Aurora CO,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Dallas TX, Houston TX, Columbus OH, Canton OH,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase1, Recruiting
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Dallas TX
Sponsor: Secretome Therapeutics
Sex: All
Age: 18+
Code: NCT06560762
Phase1, Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fairway KS,
Sponsor: Ansun Biopharma, Inc.
Sex: All
Age: 0+
Code: NCT03808922
Phase3, Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Phase3, Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
for
Cystic Fibrosis Lung
Location: Dallas TX, Kansas City KS, Birmingham AL, Denver CO,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT05248230
Phase2, Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer